Exclusive

Publication

Byline

Location

Singapore Clinical Trial: A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Phase 3 Study of Zipalertinib Plus Adjuvant Chemotherapy Versus Placebo Plus Adjuvant Chemotherapy in Stage IB-IIIA NSCLC Patients with Uncommon EGFR Mutations Following Complete Tumor Resection (REZILIENT4)

Singapore, Sept. 9 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Phase 3 Study of Zipalertinib Plus Ad... Read More


Singapore Clinical Trial: Beamion LUNG-3: A randomized, controlled, multi-center trial evaluating zongertinib as an adjuvant monotherapy compared with standard of care in patients with early-stage, resectable non-small cell lung cancer (Stage II-IIIB) harboring tyrosine kinase domain activating HER2 mutations

Singapore, Sept. 9 -- The Health Sciences Authority received information related to the study titled 'Beamion LUNG-3: A randomized, controlled, multi-center trial evaluating zongertinib as an adjuvant... Read More


Singapore Clinical Trial: A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the effects of oral TRPC6 inhibitor BI 764198 taken over a 104 week treatment period in adult and adolescent participants with primary focal segmental glomerulosclerosis (pFSGS) or genetic FSGS related to TRPC6 gene variants

Singapore, Sept. 9 -- The Health Sciences Authority received information related to the study titled 'A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the ef... Read More


Singapore Clinical Trial: A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigate the efficacy and safety of lunsekimig in adult participants with inadequately controlled chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype

Singapore, Sept. 9 -- The Health Sciences Authority received information related to the study titled 'A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigat... Read More


Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4167586 in Participants with Obesity or Overweight who are Otherwise Healthy.

Singapore, Sept. 9 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate t... Read More


Why is Indian stock market down? 3 key factors explained - Top losers contributing to the fall in Sensex, Nifty today

New Delhi, Sept. 9 -- The Indian stock market continued witnessing selling pressure for the third consecutive session on Wednesday, 9 September, tracking weak global cues. The Sensex dropped more than... Read More


Bilawal calls for parliament debate on governance crisisPublished on: September 9, 2026 10:04 AM

Pakistan, Sept. 9 -- PPP Chairman Bilawal Bhutto-Zardari has urged Interior Minister Mohsin Naqvi to debate Pakistan's governance problems in parliament. He said the country's future cannot be decided... Read More


Sensex slides 465 pts; IT shares decline

Mumbai, Sept. 9 -- The key equity benchmarks traded with major losses in the morning trade. The Nifty traded below the 23,550 mark. IT shares extended losses for the sixth consecutive trading session.... Read More


What happened to Gael? Massive search underway for missing Miami Gardens police K-9 as 'tragic' footage emerges

India, Sept. 9 -- Miami Gardens Police have launched a huge search for a missing K-9, Gael, that was struck by a vehicle. Gael was let out of a vehicle when officers responded to a business alarm in t... Read More


Larsen & Toubro secures offshore EPCIC order from ONGC

Mumbai, Sept. 9 -- L&T Energy Hydrocarbon Offshore (LTEH Offshore) has secured a large offshore order from the Oil & Natural Gas Corporation (ONGC) for the Additional Development of Ratna-I (ADR I) an... Read More